Suchergebnisse - "Hirase, Tetsuaki"

PubPharm (83)

1

Trends of HbA1c and BMI in People with Type 2 Diabetes : A Japanese Claims-Based Study

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Hara, K. | Hirase, T. | Pathadka, S. | +4

2

Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study

enthalten in: Diabetes therapy | 2024

von Hara, K. | Hirase, T. | Pathadka, S. | +4

3

Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan : A Retrospective Cross-Sectional Study

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2024

von Ishigaki, Y. | Hirase, T. | Pathadka, S. | +4

4

Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes : A subgroup analysis of the SURPASS J-mono study

enthalten in: Diabetes, obesity & metabolism | 2024

von Osonoi, T. | Oura, T. | Hirase, T.

5

Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study

enthalten in: Diabetes therapy | 2023

von Ishigaki, Y. | Hirase, T. | Pathadka, S. | +4

6

Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial

enthalten in: Journal of cardiology | 2023

von Tsutsui, H. | Sakamaki, H. | Momomura, S. | +9

7

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)

enthalten in: Diabetes, obesity & metabolism | 2023

von Kiyosue, A. | Dunn, J. | Cui, X. | +4

8

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies ( SURPASS programme)

enthalten in: Diabetes, Obesity and Metabolism | 2023

von Kiyosue, A. | Dunn, J. | Cui, X. | +4

9

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2020

von Watada, H. | Sakamaki, H. | Yabe, D. | +5

10

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the $ CARMELINA^{®} $ Trial

enthalten in: Diabetes therapy | 2020

von Watada, H. | Sakamaki, H. | Yabe, D. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]